16:12 uur 26-09-2017

Model N organiseert Weens forum voor innovatieve prijsbepaling in levenswetenschappen

Toonaangevende leidinggevenden van farmaceutische en medisch-technische bedrijven delen beste praktijkvoorbeelden voor vernieuwende prijsstrategieën en commerciële uitmuntendheid voor maximale omzet

REDWOOD CITY, Calif.–(BUSINESS WIRE)– Model N, Inc. (NYSE:MODN), de toonaangevende provider van cloud-based systemen voor revenue management in de levenswetenschappelijke sector en productiebedrijven, heeft vandaag aangekondigd het Commercial and Pricing Innovation Forum van 10 tot 12 oktober 2017 te organiseren op het Palais Hansen Kempinski in Wenen, Oostenrijk. Het Forum is opgezet om innovatie te stimuleren bij invloedrijke kopstukken uit de sector en farmaceutische, medisch-technische en technologische bedrijven.



Model N to Host Life Sciences Commercial and Pricing Innovation Forum in Vienna, Austria

Leading Pharmaceutical and MedTech Executives to Share Best Practices in Global Pricing Innovation and Commercial Excellence to Maximize Revenue

REDWOOD CITY, Calif.–(BUSINESS WIRE)– Model N, Inc. (NYSE:MODN), the leading provider of cloud-based revenue management solutions to life sciences, technology and manufacturing companies, today announced it will host the Commercial and Pricing Innovation Forum on October 10-12, 2017, at the Palais Hansen Kempinski in Vienna, Austria. The Forum is designed to drive innovation among thought leaders from industry experts and pharmaceutical, medical device and technology companies.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170925006556/en/

Model N to Host Life Sciences Commercial and Pricing Innovation Forum Oct 10-12, 2017. (Photo: Busin ... Model N to Host Life Sciences Commercial and Pricing Innovation Forum Oct 10-12, 2017. (Photo: Business Wire)

“The Life Sciences Commercial and Pricing Innovation Forum is designed to enable global pricing leaders to share best practices and to drive further innovation,” said Zack Rinat, founder, executive chairman & CEO of Model N. “We are excited to host this Forum to paint the role of Cloud technology in driving end-to-end pricing, tendering and market access.”

The Forum will bring together over 100 pharmaceutical and medical devices executives from around the globe to discuss emerging commercial-wide trends, recurring challenges faced by the industry and best practices in global pricing, tender and revenue management.

“Tender planning is top of mind for commercial and pricing teams in Life Sciences,” said Roman Irsiegler, senior marketing manager biosimilars at Pfizer. “I am delighted to join a panel on tender management during this forum, where I will zoom in on Biosimilars and present the perspective of a mature and sophisticated market where tender and contracts are essential to success.”

The two-day conference includes exclusive business cases, workshops and user discussion groups that will deliver actionable insights for pharmaceutical and medical devices executives involved with global pricing and commercial improvement programs.

Sessions include:

  • Global Pricing Strategy Throughout the Product Life Cycle
  • Innovative Contracting Models: pitfalls and critical success factors in various markets
  • Tender Management: the current state of Tendering in medical devices and pharmaceuticals, use of public data, Tender Planning, etc.
  • Market Access strategies in Emerging Markets: strategies for sustainable market access
  • Value-Based Health Care: enrich the understanding of value-based healthcare, its definition, barriers and opportunities
  • Sales Approach Transformation: from product to solution sales

For more information on the event agenda, speakers and registration, please visit the Forum’s site at www.modeln.com/CPIF2017.

About Model N

Model N is the leader in Revenue Management solutions. Driving mission critical business processes such as configure, price and quote (CPQ), contract and rebate management, business intelligence, and regulatory compliance, Model N solutions transform the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in life sciences, technology and manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com.

Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.


Model N, Inc.
Laure Gaboriaud

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is. Check out our twitter: @NewsNovumpr